BlackRock Investment Management’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-170,684
| Closed | -$249K | – | 4258 |
|
|
2016
Q1 | $249K | Buy |
170,684
+4,720
| +3% | +$6.89K | ﹤0.01% | 3105 |
|
|
2015
Q4 | $531K | Buy |
165,964
+1,778
| +1% | +$5.69K | ﹤0.01% | 2979 |
|
|
2015
Q3 | $1.03M | Sell |
164,186
-4,760
| -3% | -$29.7K | ﹤0.01% | 2576 |
|
|
2015
Q2 | $1.68M | Buy |
168,946
+42,855
| +34% | +$426K | ﹤0.01% | 2372 |
|
|
2015
Q1 | $929K | Buy |
126,091
+15,676
| +14% | +$115K | ﹤0.01% | 2567 |
|
|
2014
Q4 | $591K | Buy |
110,415
+5,707
| +5% | +$30.5K | ﹤0.01% | 2914 |
|
|
2014
Q3 | $527K | Buy |
104,708
+1,547
| +1% | +$7.79K | ﹤0.01% | 2932 |
|
|
2014
Q2 | $692K | Buy |
+103,161
| New | +$692K | ﹤0.01% | 2841 |
|